JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist
  • 51
  • -1-1.92%
20min DelayMarket Closed Sep 13 15:00 JST
4.09BMarket Cap-2800P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BrightPath Biotherapeutics Q1 2025 Earnings Date

Currency：JPYAug 9, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
0
--
-100.00%
NI to Common Holders
--
-330.00M
--
-11.58%
Analyst Rating
No Data

BrightPath Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

No Data

BrightPath Biotherapeutics Earnings Reports

  • BrightPath Biotherapeutics: 1Q financial results briefing for March 2025 [Japan standard] (non-consolidated).

    Aug 9 02:00 ET

  • BrightPath Biotherapeutics: Confirmation letter

    Jun 21 02:33 ET

  • BrightPath Biotherapeutics: Securities Report - 21st term (April 1, 2023 - March 31, 2024)

    Jun 21 02:32 ET

  • BRIGHTPATH BIOTHERAPEUTICS: (Correction) Partial Corrections to the “Financial Results Summary for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)”

    May 10 04:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data